NO914577L - Fremgangsmaate for fremstilling av heterocyklisk substituerte piperazinoalkylbenzoksazin- og -tiazinforbindelser - Google Patents

Fremgangsmaate for fremstilling av heterocyklisk substituerte piperazinoalkylbenzoksazin- og -tiazinforbindelser

Info

Publication number
NO914577L
NO914577L NO91914577A NO914577A NO914577L NO 914577 L NO914577 L NO 914577L NO 91914577 A NO91914577 A NO 91914577A NO 914577 A NO914577 A NO 914577A NO 914577 L NO914577 L NO 914577L
Authority
NO
Norway
Prior art keywords
lower alkyl
compounds
halogen
carbon atoms
hydrogen
Prior art date
Application number
NO91914577A
Other languages
English (en)
Other versions
NO914577D0 (no
Inventor
Daniel Jasserand
H Francois Floc
Richard White
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of NO914577D0 publication Critical patent/NO914577D0/no
Publication of NO914577L publication Critical patent/NO914577L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/161,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Forbindelser med den generelle formel I ;-R hvor X betyr oksygen eller svovel, Y betyr oksygen eller svovel, R1 betyr hydrogen eller lavere alkyl. R2 betyr hydrogen, lavere alkyl, halogen, lavere alkoksy, hydroksy, nitro eller tri- fluormetyl, og R3 betyr hydrogen, lavere alkyl, halogen eller lavere alkoksy, eller R2 og R3 er bundet til nabokarbonatomer og betyr til sammen en alkylendioksygruppe med 1-2 karbon- atomer, n står for et helt tall fra O til 4, og R4 står for en umettet, heterosyklisk 6-ring som inneholder l eller 2 nitrogenatomer som ikke er bundet direkte til piperazinringen, som eventuelt kan være substituert med 1-2 substituenter fra gruppen lavere alkyl, lavere alkoksy og halogen, som er bundet til karbonatomer, og syreaddi- sjonssalter derav. Forbindelsene er terapeutisk aktive. Fremstillingen av forbindelsene er beskrevet. Forbindelser med den generelle formel IV iv hvor X betyr oksygen eller svovel, R1 betyr hydrogen eller lavere alkyl, R2' betyr hydrogen, lavere alkyl, halogen, lavere alkoksy, nitro eller trifluor- metyl, R betyr hydrogen, lavere alkyl, halogen eller lavere alkoksy, eller R2' og R er bundet til nabostilte karbon- atomer og betyr til sammen en alkylen- dioksygruppe med 1-2 karbonatomer, og n står for et helt tall fra O til 4, kan anvendes som mellomprodukter ved fremstillingen av forbindelser med formel I.
NO91914577A 1990-11-24 1991-11-22 Fremgangsmaate for fremstilling av heterocyklisk substituerte piperazinoalkylbenzoksazin- og -tiazinforbindelser NO914577L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4037427A DE4037427A1 (de) 1990-11-24 1990-11-24 Heterocyclisch substituierte piperazinoalkylbenzoxazin und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
NO914577D0 NO914577D0 (no) 1991-11-22
NO914577L true NO914577L (no) 1992-05-25

Family

ID=6418854

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914577A NO914577L (no) 1990-11-24 1991-11-22 Fremgangsmaate for fremstilling av heterocyklisk substituerte piperazinoalkylbenzoksazin- og -tiazinforbindelser

Country Status (16)

Country Link
EP (1) EP0488008A1 (no)
JP (1) JPH05140156A (no)
KR (1) KR920009826A (no)
CN (1) CN1062140A (no)
AU (1) AU644496B2 (no)
CA (1) CA2056009A1 (no)
DE (1) DE4037427A1 (no)
FI (1) FI915518A (no)
HU (1) HUT62004A (no)
IE (1) IE914074A1 (no)
IL (1) IL99949A0 (no)
MX (1) MX9102192A (no)
NO (1) NO914577L (no)
PT (1) PT99570A (no)
TW (1) TW218876B (no)
ZA (1) ZA918341B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2667068B1 (fr) * 1990-09-26 1994-09-09 Adir Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
AU638154B2 (en) * 1990-10-04 1993-06-17 Suntory Limited Benzoxazine derivative and herbicide containing same as an active ingredient
AU5979494A (en) * 1993-02-05 1994-08-29 Yamanouchi Pharmaceutical Co., Ltd. Novel benzoxazine derivative, medicine containing the same, and intermediate therefor
FR2702477B1 (fr) * 1993-03-08 1995-04-28 Synthelabo Dérivés de benzoxazine, leur préparation et leur application en thérapeutique.
FR2755690B1 (fr) * 1996-11-08 1998-12-18 Adir Nouveaux derives aminomethyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1244481A (en) * 1967-11-08 1971-09-02 Wyeth John & Brother Ltd Benzothiazine derivatives and the preparation thereof
EP0186310A1 (en) * 1984-11-28 1986-07-02 Takeda Chemical Industries, Ltd. 1,4-Benzothiazine Derivatives, their production and use
EP0233728A1 (en) * 1986-02-11 1987-08-26 Takeda Chemical Industries, Ltd. 1,4-Benzoxazine derivatives their production and use
FR2667068B1 (fr) * 1990-09-26 1994-09-09 Adir Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
CA2056009A1 (en) 1992-05-25
IE914074A1 (en) 1992-06-03
DE4037427A1 (de) 1992-05-27
EP0488008A1 (de) 1992-06-03
FI915518A (fi) 1992-05-25
ZA918341B (en) 1992-07-29
KR920009826A (ko) 1992-06-25
HUT62004A (en) 1993-03-29
CN1062140A (zh) 1992-06-24
MX9102192A (es) 1994-08-31
JPH05140156A (ja) 1993-06-08
TW218876B (no) 1994-01-11
PT99570A (pt) 1992-10-30
NO914577D0 (no) 1991-11-22
AU8809191A (en) 1992-05-28
IL99949A0 (en) 1992-08-18
HU913482D0 (en) 1992-01-28
AU644496B2 (en) 1993-12-09
FI915518A0 (fi) 1991-11-22

Similar Documents

Publication Publication Date Title
DE3167757D1 (en) Dibenz(b,f)(1,4)oxazepine derivatives, process for preparing the same, and pharmaceutical compositions comprising the same
TW330202B (en) Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
DE3069408D1 (en) 5-oxo- and 5-thioxoproline derivatives, process for their production and pharmaceutical compositions containing them
NO823768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
ES2164164T3 (es) Derivados de aminotetrazol utiles como inhibidores de oxido nitrico sintasa.
DK0479546T3 (da) Piperazinderivater
ATE62686T1 (de) Neue 3-oxadiazol- und 3-carbonsaeure-betacarbolinderivate, ihre herstellung und ihre verwendung als arzneimittel.
ATE9336T1 (de) 3,1-benzoxazin-2-one, ihre herstellung und verwendung.
GB2191196B (en) Imidazo pyrimidines
ES466366A1 (es) Un procedimiento para preparar derivados de metasulfonamido-benzamida.
NO822693L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 1-fenyl-2-aminocarbonylindolforbindelser
DK326481A (da) Fremgangsmaade til fremstilling af i 5-stillingen substituerede 5,10-dihydro-11h-dibenzo (b,e) (1,4) diazepin-11-oner eller syreadditionssalte deraf
ATE13765T1 (de) 2-(1,4-benzodioxan-2-ylalkyl)-imidazole, deren herstellung und sie enthaltende pharmazeutische mittel.
NO914577L (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte piperazinoalkylbenzoksazin- og -tiazinforbindelser
ATE24509T1 (de) Triazoloquinazolone und deren salze, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen.
SE8006953L (sv) Heterocykliska foreningar
ES527739A0 (es) Un procedimiento para preparar derivados de pirimidina
ATE58536T1 (de) 5-aminoalkyl-beta-carbolinderivate, ihre herstellung und verwendung als arzneimittel.
ES471895A1 (es) Procedimiento para preparar derivados de benzamidina
SE7710958L (sv) Sett att framstella biologiskt aktiva tetracykliska foreningar
ES8304574A1 (es) Un procedimiento para la preparacion de nuevos derivados de penicilina.
NO20020291L (no) Terapeutiske og profylaktiske midler for neoplasmer
ATE914T1 (de) Heterocyclische spiroverknuepfte amidine, ihre stereoisomeren und optischen isomeren, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
SE7713864L (sv) Nortropinkarbazatderivat och forfarande for framstellning av dem
ATE22683T1 (de) Substituiertes heterocyclylphenylsulphonyl und phosphonylamidine, verfahren zu deren herstellung und deren pharmazeutische anwendung.